Las Vegas, NV -- (SBWIRE) -- 10/30/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Northstar Realty Finance Corp. (NYSE:NRF), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Titan International Inc (NYSE:TWI), MannKind Corporation (NASDAQ:MNKD)
Northstar Realty Finance Corp. (NYSE:NRF) managed to keep its fall at -1.57% on above-normal volume of 2.86M shares. The stock settled at $9.43 after floating in a range of $9.34 to $9.62. Its latest price has reached market capitalization of $9.62 million. Its 52-week range has been $5.55 to $10.30. NorthStar Realty Finance Corp. is an internally managed real estate finance company. It originates, acquires and manages portfolios of commercial real estate debt, commercial real estate securities and net lease properties.
Has NRF Found The Bottom and Ready To Move Up? Find Out Here
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) traded down on a volume of 2.82 million, higher than its standard daily volume. Shares have dropped-4.51% to $4.87. Over the last twelve months, the stock has lost-37.16% and faced a worst price of $3.76. Synta Pharmaceuticals Corp. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing small molecule drugs to severe the medical conditions of the patients with cancer and inflammatory diseases.
Has SNTA Found The Bottom And Ready To Gain Momentum? Find Out Here
Titan International Inc (NYSE:TWI) settled 5.23% higher at $15.10 on above-normal volume of 2.80M shares during the last trading day. The stock has its 12-month high at $27.12 and 52-week low price was $14.14. It traded in a range of $14.24 to $15.72 during the last trading day. Titan International, Inc. (Titan) through its subsidiaries, is engaged in the manufacturing of wheels and tires. The Company operates in three segments: agricultural, earthmoving/construction and consumer.
Why Should Investors Buy TWI After the Recent Fall? Just Go Here and Find Out
In the last trading session, MannKind Corporation (NASDAQ:MNKD) was down on low volume, trading at a volume of 2.83M shares versus its average daily volume of 5.03 million shares. At $5.23, the stock has attained market capitalization of $1.58 billion. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
Why Should Investors Buy MNKD After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)